Methimazole therapy in Graves' disease influences the abnormal expression of CD69 (early activation antigen) on T cells. (Q50904889)
Jump to navigation
Jump to search
scientific article published in December 1997
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Methimazole therapy in Graves' disease influences the abnormal expression of CD69 (early activation antigen) on T cells. |
scientific article published in December 1997 |
Statements
Methimazole therapy in Graves' disease influences the abnormal expression of CD69 (early activation antigen) on T cells (English)
J J Corrales
A López
J Ciudad
1 December 1997